Home / Recalls / Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. / D-0469-2024

D-0469-2024 Class III Ongoing

Recalled by Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. — Tokushima, N/A

Recall Details

Product Type
Drugs
Report Date
May 1, 2024
Initiation Date
April 9, 2024
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
N/A

Product Description

Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13

Reason for Recall

Cross Contamination with Other Products

Distribution Pattern

USA nationwide.

Code Information

Lot # APS00423A, Exp 07/31/2025; APS00222A, Exp 11/30/2024

Other recalls by Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.

  • D-0466-2024 Class III — Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Ots (April 9, 2024)
  • D-0468-2024 Class III — Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Ot (April 9, 2024)
  • D-0467-2024 Class III — Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 5914 (April 9, 2024)